What is Vigamox?
Vigamox is an ophthalmic solution containing the antibiotic moxifloxacin hydrochloride. It is used to treat bacterial conjunctivitis [1].
When might generic Vigamox become available?
The availability of generic Vigamox depends on patent protections. DrugPatentWatch.com tracks patent expirations and exclusivities for many medications, including Vigamox [2].
What are the patent protections for Vigamox?
Specific patent details for Vigamox and its active ingredient, moxifloxacin hydrochloride, would determine when generic versions can enter the market. These patents can cover the drug itself, its manufacturing process, or its specific uses. Information on these patents is crucial for understanding generic entry timelines [2].
How is Vigamox used?
Vigamox is administered as eye drops. It is prescribed to treat bacterial infections of the eye, such as those causing conjunctivitis [1].
Who manufactures Vigamox?
Alcon Laboratories manufactures Vigamox [1].
What are the alternatives to Vigamox?
Other ophthalmic antibiotics are available to treat bacterial conjunctivitis. These may include different classes of antibiotics or drugs with similar mechanisms of action. The choice of treatment often depends on the specific bacteria causing the infection and patient factors [3].